Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05626322 |
| Title | Effects of Maplirpacept (PF-07901801),Tafasitamab, and Lenalidomide in People With Relapsed or Refractory Diffuse Large B-cell Lymphoma |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Pfizer |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mary Bird Perkins Cancer Center | Baton Rouge | Louisiana | 70809 | United States | Details | |
| University of Michigan | Ann Arbor | Michigan | 48109 | United States | Details | |
| Lifespan Cancer Institute | Providence | Rhode Island | 02903 | United States | Details | |
| The Miriam Hospital | Providence | Rhode Island | 02906 | United States | Details | |
| Yamagata University Hospital | Yamagata | 990-9585 | Japan | Details | ||
| Dong-A University Hospital | Busan | Pusan-kwangyǒkshi | 49201 | Korea, Republic of | Details | |
| Seoul National University Hospital | Seoul | Seoul-teukbyeolsi [seoul] | 03080 | Korea, Republic of | Details |